Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study

AIM: To evaluate the changes in renal endpoints in type 2 diabetes patients treated with dapagliflozin versus other glucose‐lowering medications in routine clinical practice. MATERIALS AND METHODS: DARWIN‐T2D was a retrospective study conducted at 46 outpatient diabetes clinics in Italy. An automate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Fadini, Gian Paolo, Solini, Anna, Manca, Maria Laura, Penno, Giuseppe, Gatti, Adriano, Anichini, Roberto, Del Prato, Stefano, Avogaro, Angelo
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585815/
https://ncbi.nlm.nih.gov/pubmed/30136354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13508
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars